Target intelligence / Profile preview

X-prolyl aminopeptidase 3 (XPNPEP3)

Target
XPNPEP3
Molecular classification
Enzyme, Metallopeptidase (specifically, M24B family), Aminopeptidase
01

Overview

X-prolyl aminopeptidase 3 (XPNPEP3) is a mitochondrial and cytosolic enzyme that removes the N-terminal amino acid from peptides where a proline resides in the penultimate position, and is critical for mitochondrial protein processing and stability. It functions as a metallopeptidase (M24B family), utilizing a metal cofactor for activity, and is essential for mitochondrial proteostasis. XPNPEP3 is also involved in ciliary function, and mutations in this gene cause nephronophthisis-like ciliopathy (a cystic kidney disease). Beyond its enzymatic role, one isoform (localized to mitochondria) acts as an adaptor in TNF-TNFR2 signaling, modulating cell death pathways independently of its enzymatic activity. Structural studies reveal distinct substrate specificity and a unique pocket accommodating proline in the P1’ position[1][2][3][4][5].

Other names
Xaa-Pro aminopeptidase 3X-Pro aminopeptidase 3APP3NPHPL1ICP55Aminopeptidase P3Intermediate Cleaving Peptidase 55
02

Mechanism of action

Inhibitors may act by binding to the active site and blocking catalytic removal of the N-terminal residue (as shown with apstatin in crystal structure analyses)[1].

03

Biological functions

Removal of the N-terminal amino acid from peptides where proline is in the penultimate (second) positionMitochondrial protein processing and degradationModulation of TNF-TNFR2 (Tumor Necrosis Factor Receptor 2) signaling as an adaptor protein (independent of catalytic activity)
04

Disease associations

Cystic kidney disease (specifically, nephronophthisis-like nephropathy/ciliopathy)Mitochondrial dysfunctionPotential role in immune signaling (via TNF pathway)
05

Safety considerations

No specific safety concerns or therapeutic challenges documented, but inhibition or loss of function leads to cystic kidney disease and mitochondrial dysfunction, suggesting potential toxicity with indiscriminate inhibition[1][4]
06

Interacting drugs

apstatin
07

Biomarkers

Mutations in XPNPEP3 gene serve as biomarkers for "nephronophthisis-like nephropathy 1" and other related kidney/ciliopathy disorders[4][5]

Beyond the preview

Go deeper on X-prolyl aminopeptidase 3 (XPNPEP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on X-prolyl aminopeptidase 3 (XPNPEP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call